DD268945A5 - Verfahren zur herstellung eines dihydropyridinlactols - Google Patents
Verfahren zur herstellung eines dihydropyridinlactols Download PDFInfo
- Publication number
- DD268945A5 DD268945A5 DD86293531A DD29353186A DD268945A5 DD 268945 A5 DD268945 A5 DD 268945A5 DD 86293531 A DD86293531 A DD 86293531A DD 29353186 A DD29353186 A DD 29353186A DD 268945 A5 DD268945 A5 DD 268945A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- alkyl
- carbon atoms
- optionally
- chain
- fluorine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863601226 DE3601226A1 (de) | 1986-01-17 | 1986-01-17 | Dihydropyridinlactole, verfahren zur herstellung und ihre verwendung in arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD268945A5 true DD268945A5 (de) | 1989-06-14 |
Family
ID=6292033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86293531A DD268945A5 (de) | 1986-01-17 | 1986-08-08 | Verfahren zur herstellung eines dihydropyridinlactols |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4721719A (zh) |
| EP (1) | EP0235347B1 (zh) |
| JP (1) | JPH0762018B2 (zh) |
| KR (1) | KR870007179A (zh) |
| CN (2) | CN1019488B (zh) |
| AT (1) | ATE68184T1 (zh) |
| AU (1) | AU587068B2 (zh) |
| CA (1) | CA1293508C (zh) |
| CS (1) | CS258492B2 (zh) |
| DD (1) | DD268945A5 (zh) |
| DE (2) | DE3601226A1 (zh) |
| DK (1) | DK161252C (zh) |
| EG (1) | EG18031A (zh) |
| ES (1) | ES2009209A6 (zh) |
| FI (1) | FI870151A (zh) |
| GR (1) | GR862107B (zh) |
| HU (1) | HU196804B (zh) |
| IL (1) | IL81258A (zh) |
| NO (1) | NO164597C (zh) |
| NZ (1) | NZ217308A (zh) |
| PH (1) | PH23676A (zh) |
| PL (2) | PL149694B1 (zh) |
| PT (1) | PT84120B (zh) |
| SU (1) | SU1440345A3 (zh) |
| ZA (1) | ZA865968B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3410645A1 (de) * | 1984-03-23 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| JP2594809B2 (ja) * | 1988-04-02 | 1997-03-26 | 日本ゼオン株式会社 | タイヤトレッド用ゴム組成物 |
| JP4860050B2 (ja) * | 2001-04-23 | 2012-01-25 | 富士重工業株式会社 | 溶断装置による穿孔方法及び溶断装置 |
| AU2004272078A1 (en) * | 2003-09-10 | 2005-03-24 | Synta Pharmaceuticals Corp. | Dihydropyridine compounds for treating or preventing metabolic disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0080220B1 (en) * | 1981-11-17 | 1986-02-19 | FISONS plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
| EP0111455A3 (de) * | 1982-12-10 | 1984-07-25 | Ciba-Geigy Ag | Ungesättigte Lactone |
| DE3343658A1 (de) * | 1983-12-02 | 1985-06-13 | Bayer Ag, 5090 Leverkusen | Hydroxy-tetrahydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1986
- 1986-01-17 DE DE19863601226 patent/DE3601226A1/de not_active Withdrawn
- 1986-08-05 DK DK372586A patent/DK161252C/da not_active IP Right Cessation
- 1986-08-06 EP EP86110896A patent/EP0235347B1/de not_active Expired - Lifetime
- 1986-08-06 DE DE8686110896T patent/DE3681913D1/de not_active Expired - Lifetime
- 1986-08-06 AT AT86110896T patent/ATE68184T1/de active
- 1986-08-08 ZA ZA865968A patent/ZA865968B/xx unknown
- 1986-08-08 DD DD86293531A patent/DD268945A5/de not_active IP Right Cessation
- 1986-08-11 GR GR862107A patent/GR862107B/el unknown
- 1986-08-15 PL PL1986271190A patent/PL149694B1/pl unknown
- 1986-08-15 PL PL1986261050A patent/PL149184B1/pl unknown
- 1986-08-19 ES ES8601187A patent/ES2009209A6/es not_active Expired
- 1986-08-21 NZ NZ217308A patent/NZ217308A/xx unknown
- 1986-08-22 JP JP61195704A patent/JPH0762018B2/ja not_active Expired - Lifetime
- 1986-08-25 EG EG536/86A patent/EG18031A/xx active
- 1986-08-27 US US06/900,866 patent/US4721719A/en not_active Expired - Lifetime
- 1986-08-27 SU SU864028009A patent/SU1440345A3/ru active
- 1986-08-29 PH PH34199A patent/PH23676A/en unknown
- 1986-09-02 CA CA000517282A patent/CA1293508C/en not_active Expired - Lifetime
- 1986-09-16 KR KR1019860007764A patent/KR870007179A/ko not_active Application Discontinuation
- 1986-09-29 AU AU63233/86A patent/AU587068B2/en not_active Ceased
- 1986-10-04 CN CN86106735A patent/CN1019488B/zh not_active Expired
- 1986-10-04 CN CN91108007A patent/CN1061528A/zh active Pending
- 1986-11-03 CS CS867923A patent/CS258492B2/cs unknown
- 1986-12-29 NO NO865324A patent/NO164597C/no unknown
-
1987
- 1987-01-14 IL IL81258A patent/IL81258A/xx unknown
- 1987-01-15 FI FI870151A patent/FI870151A/fi not_active Application Discontinuation
- 1987-01-16 PT PT84120A patent/PT84120B/pt not_active IP Right Cessation
- 1987-01-16 HU HU87122A patent/HU196804B/hu not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0796846B1 (de) | 2-Aryl-substituierte Pyridine | |
| EP0258729B1 (de) | Dihydropyridinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| EP0452712B1 (de) | Neue 4-Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DD268945A5 (de) | Verfahren zur herstellung eines dihydropyridinlactols | |
| DE3542661A1 (de) | Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung | |
| EP0770082A1 (de) | Dioxo-thiopyrano-pyridin-carbonsäure-derivate und ihre verwendung als arzneimittel | |
| EP0389425B1 (de) | Neue Benzothiopyranylamine | |
| EP0088323B1 (de) | Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln | |
| EP0519291A1 (de) | Aminomethyl-substituierte 2,3-Dihydropyrano(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| EP0308785B1 (de) | Dihydropyridinether, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| EP0231511B1 (de) | A-Aminoaryldihydropyridinlactone, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DE3520104A1 (de) | Naphthoxazine, ihre herstellung und verwendung | |
| EP0229963B1 (de) | 4-Thienyl-dihydropyridine, Verfahren zur Herstellung und ihre Verwendung in Arzneimitteln | |
| DE3020421A1 (de) | Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln | |
| EP0001439B1 (de) | 1-N-substituierte 1.4-Dihydropyridazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung für Arzneimittel | |
| AT368495B (de) | Verfahren zur hestellung von neuen nitrosubstituierten 1,4-dihydropyridinen | |
| DE3329621A1 (de) | Aminoalkyl-imidazothiadiazol-alkencarbonsaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln | |
| DE3528601A1 (de) | Hydropyrane, verfahren zur herstellung und ihre verwendung | |
| AT368494B (de) | Verfahren zur herstellung von neuen nitrosubstituierten 1,4-dihydropyridinen | |
| EP0281789B1 (de) | Benzylaminoaryl-dihydropyridinelactone, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DE3624102A1 (de) | Substituierte pyrrolidone, verfahren zur herstellung und ihre verwendung | |
| DE3808136A1 (de) | Arzneimittel, enthaltend chinolin-2,5-dione, neue chinolin-2,5-dione und verfahren zu ihrer herstellung | |
| EP0758647A1 (de) | Acyl-substituierte Aminopyrane mit einer modulierende Wirkung auf Kaliumkanäle | |
| DE3615404A1 (de) | Salze von 3-amino-dihydropyridinen, ein verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| EP0224809A1 (de) | Imidazothiadiazinalkensäureamide, Verfahren zu ihrer Herstellung, Zwischenprodukte zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |